A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

NCT ID: NCT04681352

Last Updated: 2024-01-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

99 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-29

Study Completion Date

2022-02-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate the safety and effectiveness of the Octave System for improving lines and wrinkles of the décolleté.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Décolleté Wrinkles

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

While there was only one arm, Outcome Assessors were masked to pre- vs post-treatment images.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Octave System

Single treatment of décolleté tissue.

Group Type EXPERIMENTAL

Octave-Ultherapy treatment

Intervention Type DEVICE

Micro-focused ultrasound delivered below the surface of the skin.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Octave-Ultherapy treatment

Micro-focused ultrasound delivered below the surface of the skin.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Moderate to severe fine lines, wrinkles, laxity, and crepiness of the décolleté that is amenable to improvement with non-invasive intervention and is not severe enough for surgical intervention.

Exclusion Criteria

* Presence of an active systemic or local skin disease that may affect wound healing.
* Scarring in area(s) to be treated.
* Active implants (e.g., pacemakers or defibrillators), ports, or metallic implants in area(s) to be treated.
* Breast implants or is planning to receive breast implants during the study.
* Inability to take pre-treatment medications due to a pre-existing condition, medication allergy, or medical issue that, at the discretion of the treating investigator, is contraindicated.
Minimum Eligible Age

35 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ulthera, Inc

INDUSTRY

Sponsor Role collaborator

Merz North America, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Merz Medical Expert

Role: STUDY_DIRECTOR

Merz North America, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Merz Investigational Site #0010395

Beverly Hills, California, United States

Site Status

Merz Investigational Site #0010321

San Mateo, California, United States

Site Status

Merz Investigational Site #0010352

Norwalk, Connecticut, United States

Site Status

Merz Investigational Site #0010416

Miami, Florida, United States

Site Status

Merz Investigational Site #0010346

Chicago, Illinois, United States

Site Status

Merz Investigational Site #0010439

New York, New York, United States

Site Status

Merz Investigational Site #0010452

New York, New York, United States

Site Status

Merz Investigational Site #0010396

Wilmington, North Carolina, United States

Site Status

Merz Investigational Site #0010125

Plano, Texas, United States

Site Status

Merz Investigational Site #0010392

Spokane, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M960101003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.